RxDoctor Payments DataLook up a doctor →

Robert Weinstock, MD

Ophthalmology · Largo, FLNPI 1376541664

Payments from drug & device makers

$854,732in general payments, 2019–2025

Across 584 payments — averaging $1463.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rxsight Inc$222K
  • Lensar, Inc.$193K
  • Beaver-visitec International, Inc.$98K
  • Eyepoint US, Inc.$77K
  • Alcon$71K
  • Bausch & Lomb Americas Inc.$62K
  • plus $131K from 25 others
$15,582in research payments, 2019–2025

Across 32 payments — averaging $486.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$16K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$854,732 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida

Medicare billing

Part B allowed, 2024
$473,213
Medicare patients
745
Services billed
2,899

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Largo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →